166 related articles for article (PubMed ID: 15592308)
1. Misoprostol versus methylergometrine: pharmacokinetics in human milk.
Vogel D; Burkhardt T; Rentsch K; Schweer H; Watzer B; Zimmermann R; Von Mandach U
Am J Obstet Gynecol; 2004 Dec; 191(6):2168-73. PubMed ID: 15592308
[TBL] [Abstract][Full Text] [Related]
2. Oral misoprostol for the prevention of primary post-partum hemorrhage during third stage of labor.
Enakpene CA; Morhason-Bello IO; Enakpene EO; Arowojolu AO; Omigbodun AO
J Obstet Gynaecol Res; 2007 Dec; 33(6):810-7. PubMed ID: 18001447
[TBL] [Abstract][Full Text] [Related]
3. Misoprostol compared with methylergometrine for the prevention of postpartum haemorrhage: a double-blind randomised trial.
Amant F; Spitz B; Timmerman D; Corremans A; Van Assche FA
Br J Obstet Gynaecol; 1999 Oct; 106(10):1066-70. PubMed ID: 10519433
[TBL] [Abstract][Full Text] [Related]
4. Sublingual misoprostol versus methylergometrine for active management of the third stage of labor.
Vimala N; Mittal S; Kumar S; Dadhwal V; Mehta S
Int J Gynaecol Obstet; 2004 Oct; 87(1):1-5. PubMed ID: 15464767
[TBL] [Abstract][Full Text] [Related]
5. Oral misoprostol versus injectable methylergometrine in management of the third stage of labor.
Garg P; Batra S; Gandhi G
Int J Gynaecol Obstet; 2005 Nov; 91(2):160-1. PubMed ID: 16126208
[No Abstract] [Full Text] [Related]
6. Comparison of sublingual misoprostol, intravenous oxytocin, and intravenous methylergometrine in active management of the third stage of labor.
Singh G; Radhakrishnan G; Guleria K
Int J Gynaecol Obstet; 2009 Nov; 107(2):130-4. PubMed ID: 19628206
[TBL] [Abstract][Full Text] [Related]
7. Oral misoprostol is rapidly absorbed in postpartum women at term.
Andolina KL; Tolosa JE; Monzo JM; Roberts NS; Daly S
J Matern Fetal Neonatal Med; 2003 Oct; 14(4):229-32. PubMed ID: 14738167
[TBL] [Abstract][Full Text] [Related]
8. Is rectal misoprostol really effective in the treatment of third stage of labor? A randomized controlled trial.
Calişkan E; Meydanli MM; Dilbaz B; Aykan B; Sönmezer M; Haberal A
Am J Obstet Gynecol; 2002 Oct; 187(4):1038-45. PubMed ID: 12389002
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of rectal misoprostol as second-line therapy for the treatment of primary postpartum hemorrhage.
Baruah M; Cohn GM
J Reprod Med; 2008 Mar; 53(3):203-6. PubMed ID: 18441726
[TBL] [Abstract][Full Text] [Related]
10. Low-dose sublingual misoprostol versus methylergometrine for active management of the third stage of labor.
Chhabra S; Tickoo C
J Obstet Gynaecol Res; 2008 Oct; 34(5):820-3. PubMed ID: 18834340
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the bioavailability and pharmacokinetics of oral methylergometrine in men and women.
de Groot AN; Vree TB; Hekster YA; van den Biggelaar-Martea M; van Dongen PW; van Roosmalen J
Int J Clin Pharmacol Ther; 1995 Jun; 33(6):328-32. PubMed ID: 7582383
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of methylergometrine in human breast milk by solid-phase extraction and high-performance liquid chromatography with fluorimetric detection.
Nakamichi T; Yawata A; Hojo H; Kagaya H; Kobayashi S; Chikuma T
Pharmazie; 2012 Jun; 67(6):482-4. PubMed ID: 22822533
[TBL] [Abstract][Full Text] [Related]
13. Buccal misoprostol to prevent hemorrhage at cesarean delivery: a randomized study.
Hamm J; Russell Z; Botha T; Carlan SJ; Richichi K
Am J Obstet Gynecol; 2005 May; 192(5):1404-6. PubMed ID: 15902121
[TBL] [Abstract][Full Text] [Related]
14. Excretion of methylergometrine (methylergonovine) into the human breast milk.
Erkkola R; Kanto J; Allonen H; Kleimola T; Mäntylä R
Int J Clin Pharmacol Biopharm; 1978 Dec; 16(12):579-80. PubMed ID: 730424
[TBL] [Abstract][Full Text] [Related]
15. Prevention of postpartum hemorrhage by uterotonic agents: comparison of oxytocin and methylergometrine in the management of the third stage of labor.
Fujimoto M; Takeuchi K; Sugimoto M; Maruo T
Acta Obstet Gynecol Scand; 2006; 85(11):1310-4. PubMed ID: 17091409
[TBL] [Abstract][Full Text] [Related]
16. Uterotonic Medications: Oxytocin, Methylergonovine, Carboprost, Misoprostol.
Vallera C; Choi LO; Cha CM; Hong RW
Anesthesiol Clin; 2017 Jun; 35(2):207-219. PubMed ID: 28526143
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of a controlled-release misoprostol vaginal insert at term.
Rayburn WF; Powers BL; Plasse TF; Carr D; Di Spirito M
J Soc Gynecol Investig; 2006 Feb; 13(2):112-7. PubMed ID: 16443504
[TBL] [Abstract][Full Text] [Related]
18. Misoprostol for postpartum haemorrhage.
Drug Ther Bull; 2010 Jun; 48(6):66-9. PubMed ID: 20530028
[TBL] [Abstract][Full Text] [Related]
19. Sublingual misoprostol for the prevention of postpartum hemorrhage.
Al-Harazi AH; Frass KA
Saudi Med J; 2009 Jul; 30(7):912-6. PubMed ID: 19618006
[TBL] [Abstract][Full Text] [Related]
20. Placebo-controlled randomized comparison of vaginal with rectal misoprostol in the prevention of postpartum hemorrhage.
Ozkaya O; Sezik M; Kaya H; Desdicioglu R; Dittrich R
J Obstet Gynaecol Res; 2005 Oct; 31(5):389-93. PubMed ID: 16176505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
